Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Gränges in merger control matters in connection with the acquisition of Impexmetal (Aluminium Konin)
Mandate

Vinge has advised Gränges in merger control matters in connection with the acquisition of Impexmetal (Aluminium Konin)

December 08, 2020 EU, Competition and Regulatory

Vinge has advised Gränges AB (publ) in merger control matters in connection with the acquisition of Impexmetal (Aluminium Konin).

The concentration was notified to, inter alia, the European Commission. After a thorough pre-nonfiction phase and formal review, which included several market contacts, the concentration, which results in a combination of the parties’ production of flat rolled aluminium products in the EU, was unconditionally approved by the European Commission after a phase 1 review on the 23 September 2020.

The decision is available at:  https://ec.europa.eu/competition/mergers/cases1/202050/m9560_488_3.pdf

Vinge’s team consisted mainly of Pär Remnelid, Johan Wahlbom and Julia Söderdahl.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026